BDBM141433 US10668051, Compound Example 92::US8921364, 92
SMILES: Fc1cc(NC(=O)c2c(Cl)cncc2Cl)ccc1-n1nc(cc1C1CC1)C(F)(F)F
InChI Key: InChIKey=OYBILUBTBUJCSL-UHFFFAOYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calcium release-activated calcium channel protein 1 (Homo sapiens (Human)) | BDBM141433 (US10668051, Compound Example 92 | US8921364, 92) | KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 159 | n/a | n/a | n/a | n/a | n/a | n/a |
RHIZEN PHARMACEUTICALS SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur... | US Patent US10668051 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EF-hand calcium-binding domain-containing protein 4B (Homo sapiens (Human)) | BDBM141433 (US10668051, Compound Example 92 | US8921364, 92) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 159 | n/a | n/a | n/a | n/a | n/a | 37 |
Rhizen Pharmaceuticals SA US Patent | Assay Description Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu... | US Patent US8921364 (2014) BindingDB Entry DOI: 10.7270/Q2N58K3N | |||||||||||
More data for this Ligand-Target Pair |